Brain zaps show promise for silencing hallucinations
NCT ID NCT02769507
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a non-invasive brain stimulation technique called tDCS can reduce auditory hallucinations in people with psychotic disorders. Twenty-four participants received the stimulation while researchers measured changes in hallucination severity and brain activity. The goal was to see if this safe, drug-free approach could offer relief for a distressing symptom.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial direct current stimulation (tDCS) device
- What this could lead to
- If it works, this could point toward a non-drug treatment to ease auditory hallucinations in people with psychosis.
- What could go wrong
- This is a small, early study with only 24 participants. Results may not apply to everyone, and the effect may be modest or not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Start date
-
Jul 2016
- Finished
-
Mar 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with schizophrenia spectrum disorder or other psychotic disorder * Frequent auditory hallucinations (at least 5 times a week). * Patients are on a stable dose of antipsychotic medication (which can also be zero) for at least 2 weeks. * Mentally competent for informed consent. * Provided informed consent. Exclusion Criteria: * Metal objects in or around the head that cannot be removed (i.e. cochlear implant, surgical clips, piercing) * History of seizures, or a history of seizures in first-degree relatives. * History of eye trauma with a metal object or professional metal workers * History of brain surgery, brain infarction, head trauma, cerebrovascular accident, broken skull, brain tumour, heart disease, cardiac pacemaker. * Skin disease on the scalp on the position of the tDCS electrodes * Coercive treatment based on a judicial ruling * Pregnancy in female patients
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Psychosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Bergen
Bergen, Hordaland, 5009, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists build a computer model of the brain to explain hearing voices
- Can schools catch teen mental health struggles before they escalate?
- Can a phone app curb cannabis use in early psychosis?
- Can a nasal insulin spray rev up brain energy and sharpen thinking in psychosis?
- Can virtual reality from home sharpen social skills in schizophrenia?
- Brain zaps in fast forward: a new hope for psychosis prevention?